Bio Essence Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.163342 million compared to USD 0.174992 million a year ago. Revenue was USD 0.192052 million compared to USD 0.22699 million a year ago. Net loss was USD 0.199233 million compared to USD 0.183037 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.483432 million compared to USD 0.545713 million a year ago. Revenue was USD 0.786602 million compared to USD 0.674945 million a year ago. Net loss was USD 0.596548 million compared to USD 0.55693 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.